BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1386866)

  • 1. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines.
    Nair S; Zhou X; Huang L; Rouse BT
    J Immunol Methods; 1992 Aug; 152(2):237-43. PubMed ID: 1386866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
    Chen W; Carbone FR; McCluskey J
    J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
    Carbone FR; Bevan MJ
    J Exp Med; 1990 Feb; 171(2):377-87. PubMed ID: 2137512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein.
    Reddy R; Zhou F; Huang L; Carbone F; Bevan M; Rouse BT
    J Immunol Methods; 1991 Aug; 141(2):157-63. PubMed ID: 1880423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.
    Nakanishi T; Hayashi A; Kunisawa J; Tsutsumi Y; Tanaka K; Yashiro-Ohtani Y; Nakanishi M; Fujiwara H; Hamaoka T; Mayumi T
    Eur J Immunol; 2000 Jun; 30(6):1740-7. PubMed ID: 10898512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
    Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and kinetics of MHC class I-restricted presentation of a soluble antigen delivered by liposomes.
    Zhou F; Watkins SC; Huang L
    Immunobiology; 1994 Feb; 190(1-2):35-52. PubMed ID: 8082886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of soluble protein into the class I pathway of antigen processing and presentation.
    Moore MW; Carbone FR; Bevan MJ
    Cell; 1988 Sep; 54(6):777-85. PubMed ID: 3261634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
    Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
    Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved method of loading pH-sensitive liposomes with soluble proteins for class I restricted antigen presentation.
    Zhou F; Rouse BT; Huang L
    J Immunol Methods; 1991 Dec; 145(1-2):143-52. PubMed ID: 1765645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
    Heeg K; Kuon W; Wagner H
    Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
    Rock KL; Rothstein L; Fleischacker C; Gamble S
    J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
    Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
    Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway.
    Suzue K; Zhou X; Eisen HN; Young RA
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13146-51. PubMed ID: 9371814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants.
    Sheikh NA; Rajananthanan P; Attard GS; Morrow WJ
    Vaccine; 1999 Aug; 17(23-24):2974-82. PubMed ID: 10462232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes.
    Wu JY; Gardner BH; Kushner NN; Pozzi LA; Kensil CR; Cloutier PA; Coughlin RT; Newman MJ
    Cell Immunol; 1994 Apr; 154(1):393-406. PubMed ID: 7907530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.